
-
Solid gold, royal missives and Nobel noms: how to win Trump over
-
Canadian teen Mboko outlasts Osaka to win WTA Montreal crown
-
Trump to host Armenia, Azerbaijan for historic 'Peace Signing'
-
Israeli airline's Paris offices daubed with red paint, slogans
-
US raises bounty on Venezuela's Maduro to $50 mn
-
Lebanon cabinet meets again on Hezbollah disarmament
-
France's huge wildfire will burn for days: authorities
-
Bolivia right-wing presidential hopeful vows 'radical change'
-
Trump says would meet Putin without Zelensky sit-down
-
Trump offers data to justify firing of labor stats chief
-
Bhatia leads by one at PGA St. Jude, Scheffler five adrift
-
Disney settles Trump-supporting 'Star Wars' actor lawsuit
-
Trump moves to kill $7 billion in solar panel grants
-
Venus Williams falls at first hurdle in Cincinnati
-
Mixed day for global stocks as latest Trump levies take effect
-
SpaceX agrees to take Italian experiments to Mars
-
US judge orders temporary halt to new 'Alligator Alcatraz' construction
-
US uses war rhetoric, Superman to recruit for migrant crackdown
-
US to rewrite its past national climate reports
-
U can't pay this: MC Hammer sued over delinquent car loan
-
WHO says nearly 100,000 struck with cholera in Sudan
-
Huge wildfire in southern France now under control
-
Kane scores as Bayern thump Spurs in pre-season friendly
-
France strikes down return of banned bee-killing pesticide
-
Canada sends troops to eastern province as fire damage grows
-
OpenAI releases ChatGPT-5 as AI race accelerates
-
Plastic pollution treaty talks deadlocked
-
A French sailor's personal 'Plastic Odyssey'
-
Netanyahu says Israel to control not govern Gaza
-
Partey signs for Villarreal while on bail for rape charges
-
Wales have the talent to rise again, says rugby head coach Tandy
-
US partners seek relief as Trump tariffs upend global trade
-
Five England players nominated for women's Ballon d'Or
-
PSG dominate list of men's Ballon D'Or nominees
-
Americans eating (slightly) less ultra-processed food
-
Man Utd agree 85m euro deal to sign Sesko: reports
-
France to rule on controversial bee-killing pesticide bill
-
Germany factory output falls to lowest since pandemic in 2020
-
Swiss to seek more talks with US as 'horror' tariffs kick in
-
Barcelona strip Ter Stegen of captain's armband
-
Trump demands new US census as redistricting war spreads
-
'How much worse could it get?' Gazans fear full occupation
-
France seeks to 'stabilise' wildfire raging in south
-
Ski world champion Venier quits, saying hunger has gone
-
Israel security cabinet to discuss Gaza war plans
-
Deadly Indian Himalayan flood likely caused by glacier collapse, experts say
-
UK pensioner, student arrested for backing Palestine Action
-
Israeli security cabinet to discuss future Gaza war plans
-
Antonio to leave West Ham after car crash
-
Kremlin says Trump-Putin meeting agreed for 'coming days'
RBGPF | 1.42% | 76 | $ | |
VOD | -0.36% | 11.26 | $ | |
BTI | 0.51% | 56.69 | $ | |
CMSC | 0.04% | 22.96 | $ | |
BP | 0.91% | 34.19 | $ | |
GSK | 2.21% | 37.58 | $ | |
SCU | 0% | 12.72 | $ | |
RYCEF | -0.21% | 14.45 | $ | |
RIO | 1.12% | 60.77 | $ | |
RELX | 1.03% | 49.32 | $ | |
SCS | 0.06% | 16 | $ | |
NGG | -0.31% | 72.08 | $ | |
BCC | 0.32% | 83.19 | $ | |
CMSD | -0.09% | 23.52 | $ | |
BCE | 2.23% | 23.78 | $ | |
JRI | 0.52% | 13.41 | $ | |
AZN | 1.3% | 74.57 | $ |

Warmer noses are better at fighting colds: study
Chilly weather and common respiratory infections often go hand in hand.
Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.
Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.
These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.
The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.
"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.
For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?
To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.
They found it did in fact produce EVs that target viruses.
In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.
These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.
Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.
But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.
"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.
"This is the first quantitative and biologically plausible explanation that has been developed."
One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.
"That's an area of great interest for us and we certainly continue to pursue that," he said.
C.Hamad--SF-PST